CA
TAK icon

CoreCap Advisors’s Takeda Pharmaceutical TAK Stock Holding History

CoreCap Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-75
Closed -$993 – 3295
2024
Q4 		$993 Hold
75
– – ﹤0.01% 2377
2024
Q3 		$1.07K Buy
+75
New +$1.06K ﹤0.01% 2261
2024
Q2 		– Sell
-75
Closed -$1.04K – 2466
2024
Q1 		$1.04K Buy
+75
New +$1.09K ﹤0.01% 2218
2022
Q4 		$1.17K Buy
+75
New +$1.05K ﹤0.01% 2024
2022
Q3 		– Sell
-220
Closed -$3K – 1904
2022
Q2 		$3K Buy
+220
New +$3.14K ﹤0.01% 1813
2022
Q1 		– Sell
-727
Closed -$10K – 1908
2021
Q4 		$10K Buy
+727
New +$10.2K ﹤0.01% 1557

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return